Skip to main content
. 2009 Mar;19(3):233–240. doi: 10.1089/thy.2008.0321

Table 3.

Summary of Clinical Features of Three Longest-Term Survivors

Case nos. Site Age (years), sex Stage (metastatic sites) Prior therapy No. of cycles EFS (months) OS (months)
9 Cleveland 65, M T4N0M1 (lung) Surgery 19 20 37.9
18 Detroit 60, F T4NxM1 (lung) Surgery + dox + XRT 8.67 8.8 24.4+
21 Cleveland 53, F T4N0M1 (lung) Surgery 4 3.1 15.9

M, male; F, female; dox, doxorubicin; XRT, radiation; EFS, event-free survival; OS, overall survival.